A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of 7-day repeated oral administration of OPC-41061 15 mg
or placebo in congestive heart failure (CHF) patients with extracellular volume expansion
despite the use of a conventional diuretic.